CT Urography & MR Urography Protocols

Think of the urinary tract as a plumbing system: two filters (the kidneys) up top, two pipes (the ureters) running down, and a holding tank (the bladder) at the bottom. When something goes wrong — blood in the urine, a suspicious mass, a pipe that won't drain — you want to see the whole system at once, water and all. That is exactly what a urogram does: it makes the urine itself visible so you can trace it from the filter to the tank and spot anything blocking, narrowing, or growing into the flow.

Why we time the phases (the whole trick)

Here is the thing people get hung up on: a urogram isn't one picture, it's a sequence. After iodinated contrast goes in through an IV, it does a predictable little tour of the kidneys, and we snap images at the moments that matter most.

The classic CTU has three useful looks:

That excretory phase is the star of the show. Once the kidney has done its job and dumped contrast into the urine, the entire drainage system glows white. Any tumor growing into that channel shows up as a dark filling defect — like a pebble dropped into a glass of milk.

The protocols

The ESUR CT urography working group boiled the design choice down to one fork in the road: do you want the nephrographic and excretory information on one scan (fewer acquisitions, less dose, at the cost of some compromise in each) or on two (a clean look at each, at more dose)? Everything else — hydration, diuretic, positioning — is local seasoning. I'm deliberately not quoting phase timings, contrast volumes, or injection rates here, because those vary between departments and the numbers on this page are limited to what the guideline pins down.

Getting the pipes to fill (the practical hassles)

Opacifying a long, floppy ureter evenly is genuinely annoying, because ureters contract in waves (peristalsis) and don't sit still and full like a garden hose left running. A ureter caught mid-squeeze can look falsely narrowed, and an unopacified stretch can hide a real lesion or invent a fake one.

So radiology has accumulated a small bag of tricks to coax the whole system to fill at once. These vary by practice, but commonly include giving extra fluid or a diuretic to boost urine flow, compression, and turning the patient prone or rolling them before the excretory scan so gravity drags contrast into stubborn segments. The split-bolus technique is the dose-saving trick: by putting the nephrographic and excretory phases on a single acquisition, you scan once instead of twice.

Dose: matching the radiation to the question

CTU is not a low-dose exam, and the guideline is refreshingly explicit that the dose should scale with what you're afraid of. For benign conditions — a stone follow-up, a known stricture, a congenital anomaly — the target band is a CTDIvol of 5–6 mGy. For potential malignant disease — the hematuria workup where upper tract urothelial carcinoma is on the table — the band rises to 9–12 mGy, because a missed small urothelial lesion costs more than the extra dose. The optional unenhanced series, when it's needed for stones, is run at 2–3 mGy rather than full dose. Whatever you do, every phase you acquire adds dose, which is the whole argument for the split bolus in a young patient.

How good is the test

For its headline job, CTU is excellent: in patients presenting with hematuria, the pooled sensitivity of CT urography for upper urinary tract urothelial carcinoma is 96% (95% CI 88–100%) and the pooled specificity is 99% (95% CI 98–100%), from a systematic review and meta-analysis. That is why CTU is the default upper-tract test for hematuria in adults and why the urothelial cancer workup leans on it. There is no comparable robust pooled accuracy figure for MR urography, and I'd rather say that than borrow one.

When to reach for MR instead

CT urography is fantastic, but it has two costs: ionizing radiation and a need for iodinated contrast. When either is a dealbreaker — a young patient who'll need repeat imaging over decades, a pregnant patient, or someone with a contrast allergy — MR urography steps in.

MRU comes in two genuinely different versions, and it helps to keep them straight:

• Static-fluid (T2-weighted) MRU uses heavily T2-weighted sequences where any standing fluid — urine — blazes bright on its own. No contrast needed. This shines when the system is dilated and full of urine already, like a backed-up, obstructed pipe.
• Excretory MRU uses IV gadolinium, which the kidney filters into the urine just like iodine, then images during the excretory phase. This needs flowing urine to work, so it's the better look at a non-dilated system.

A safety footnote: gadolinium carries its own caution in patients with poor kidney function, which is its own rabbit hole worth reading — see contrast nephropathy and NSF.

What these exams are actually for

Most of the time, the order lands on your desk for one of a few reasons: blood in the urine (hematuria) that needs the whole tract surveyed, surveillance of a known urothelial bladder tumor, characterizing a renal mass, or mapping anatomy before surgery. CTU is the default for hematuria in adults; MRU is the radiation-and-iodine-sparing substitute.

If you remember one thing: a urogram is a timed exam built to make urine visible. Pick the phase strategy, the dose band, and the modality to match the question, and the rest is just following the water downhill.